PreciVax Therapeutics

PreciVax Therapeutics is developing innovative vaccines for drug-resistant bacterial infections. The company first launched its product which is a vaccine for Methicillin-resistant Staphylococcus aureus (MRSA).

Company NamePreciVax Therapeutics
Brand NamePreciVax Therapeutics
IndustriesHealthcare
Year of Establishment2017
Founder(s)Qiubin LIn
No. of Employees1-10
Regional CoverageHong Kong
Clients/
Stage/
Investor(s)/
Fundraising History/
Raising Fund/
Fundraising target/
Pre-money valuation/
Post-money Valuation/
Media Exposure
Company Email

[dcb id=5586]

Leave a Reply

Your email address will not be published. Required fields are marked *